Quit-Smoking Drug Chantix May Also Help Folks Stop Vaping
By Dennis Thompson HealthDay Reporter
TUESDAY, May 21, 2024 -- A quit-smoking drug appears to help people drop their vaping addiction, a new study shows.
Vapers who took varenicline (Chantix) were significantly more likely to quit using e-cigarettes loaded with nicotine than those randomly assigned to receive a placebo, researchers found.
“We had a 15 percent difference in quit rates, with those in the medication group having a quit rate of 45 percent,” said lead researcher Lisa Fucito, director of the Tobacco Treatment Service at the Yale Cancer Center in New Haven, Conn.
Varenicline is a pill that helps people quit smoking by blocking the pleasant effects of nicotine on the brain, according to the National Institutes of Health.
It’s long been approved by the U.S. Food and Drug Administration to help people stop smoking tobacco cigarettes, so researchers wondered if it could be used to help quit e-cigarettes.
“People can get to very high levels of nicotine exposure with these e-cigarette products, and they can use them near constantly throughout the day. So, the question we all have is, ‘Can any pharmacotherapy stand up to this challenge?’” Fucito said in a Yale news release.
About 5% of U.S. adults use e-cigarettes, a number that rises to nearly 15% among young adults 18 to 24.
The new study involved 40 patients randomly assigned to take either varenicline or a placebo pill.
All participants underwent eight weeks of treatment. Along with the pills, they also got a booklet on vaping cessation and a single counseling session.
About 45% of the varenicline patients had successfully quit vaping after eight weeks, compared with 30% of the patients receiving a placebo, results show.
The new study was published May 16 in the American Journal of Preventive Medicine.
Based on these results, large-scale trials should be undertaken to confirm that varenicline can help patients quit vaping, the researchers concluded.
“We need more pharmacotherapy treatments to help address the really strong physical dependence that can develop from e-cigarette use," Fucito said. "People undergo significant withdrawal when they try to stop, and that withdrawal is so unpleasant and hard to manage with just behavioral support alone."
Sources
- Yale School of Medicine, news release, May 16, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
FDA Allows Marketing of Vuse Tobacco-Flavored Vapes
FRIDAY, July 19, 2024 -- The U.S. Food and Drug Administration on Thursday authorized the sale of the country's best-selling e-cigarette. The agency's decision only applies to...
Four in 10 Cancer Cases, Nearly Half of Cancer Deaths Linked to Lifestyle
FRIDAY, July 12, 2024 -- Nearly half of cancer deaths and 4 of 10 cases of cancer are linked to a person’s lifestyle, a new study says. Cigarette smoking remains the...
Cigarettes Worse Than Vaping for Secondhand Smoke Exposure
FRIDAY, July 12, 2024 -- Secondhand smoke from cigarettes is much worse than that from vaping, in terms of exposing children to nicotine, a new study finds. Children exposed to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
